← Leaderboards
Thomas J Walsh
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Amphotericin B”
- David R Boulware · University Of Minnesota$10,771,034
- Sergey A Kozmin · University Of Chicago$9,892,654
- Thuy Le · Duke University$7,727,050
- Martin D Burke · University Of Illinois At Urbana-Champaign$7,624,647
- David Bisagaya Meya · Infectious Diseases Institute$6,087,883
- Joseph Heitman · Duke University$4,264,829
Research focus
Amphotericin BAntifungal AgentsAspergillosisCandidiasisAids TherapyMycosisItraconazolePediatric Neoplasm /CancerHuman Therapy EvaluationImmunosuppressionMicroorganism Disease ChemotherapyPediatric AidsHuman SubjectOpportunistic InfectionsNosocomial InfectionsMonocyteBone Marrow TransplantationMucosal ImmunityPatient Oriented ResearchImmunodeficiencyCytokineClinical Trial Phase ICancer ComplicationClinical Research
Grant awards (10)
Treatment of Infections in Immunocompromised Children$2,414,206
ZIA · FY2009 · CA · contact PI
Treatment of Infections in Immunocompromised Children$2,609,501
Z01 · FY2008 · CA · contact PI
Treatment of Infections in Immunocompromised Children with Cancer, Hematopoietic$3,141,379
Z01 · FY2007 · CA · contact PI
Treatment of Infections in Immunocompromised Children wi$0
Z01 · FY2006 · SC · contact PI
Treatment of Infections in Immunocompromised Children wi$0
Z01 · FY2005 · SC
Treatment of Infections in Immunocompromised Children$0
Z01 · FY2004 · SC
Treatment of Infections in Immunocompromised Children wi$0
Z01 · FY2003 · SC
Treatment of Infections in Immunocompromised Children wi$0
Z01 · FY2002 · SC
Treatment of Infections in Immunocompromised Children wi$0
Z01 · FY2001 · SC
TREATMENT OF INFECTIONS IN IMMUNOCOMPROMISED CHILDREN WI$0
Z01 · FY2000 · SC